Portal de Periódicos da CAPES

Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020

2021; Centers for Disease Control and Prevention; Volume: 70; Issue: 2 Linguagem: Inglês

10.15585/mmwr.mm7002e3

1545-861X

Christopher Prestel, Erica Anderson, Kaitlin Forsberg, Meghan Lyman, Marie A. de Perio, David T. Kuhar, Kendra Edwards, Maria Rivera, Alicia Shugart, Maroya Spalding Walters, Nychie Dotson,

Antibiotic Use and Resistance

In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.